March 18, 2024 Columns by Leigh Anne Nelson My nearly 20-year journey to get my diagnosis of MS Hi! I’m new — not to having multiple sclerosis (MS), but to being a columnist. I’m a daughter, wife, mother of two young adults, dog mom, sister, aunt, friend, college professor, pharmacist, avid reader, nature lover, and an MS warrior. I was diagnosed with MS in 2014, although…
March 18, 2024 News by Andrea Lobo, PhD MSAA, Lumina partner to provide MRIs to MS patients in Ohio Lumina Imaging has partnered with the Multiple Sclerosis Association of America (MSAA) to provide affordable brain and spinal cord MRI scans to multiple sclerosis (MS) patients. The partnership makes Lumina the preferred provider for the MSAA’s MRI Access Program in northeast Ohio. The program is designed…
March 18, 2024 News by Lindsey Shapiro, PhD Cell therapy using Tregs in MS headed to Phase 2 trials in Poland The Polish biotechnology company PolTREG plans to launch Phase 2 trials testing its Tregs therapy — the T-cell-based treatment PTG-007 — in people with multiple sclerosis (MS) in Poland later this year. The biotech company has earned a Current Good Manufacturing Practice (CGMP) certification for its new manufacturing…
March 15, 2024 News by Steve Bryson, PhD New bilingual graphic aims to raise awareness of early MS symptoms A bilingual graphic educational message, dubbed VISIBL-MS, has been developed by researchers at the University of Connecticut (UConn) to raise awareness about the early symptoms of multiple sclerosis (MS). The graphic — bearing the word “VISIBLY” in English and “VISIBLE” in Spanish — uses the letters in each phrase…